A detailed history of Pathstone Family Office, LLC transactions in Organon & Co. stock. As of the latest transaction made, Pathstone Family Office, LLC holds 23,823 shares of OGN stock, worth $354,724. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,823
Previous 12,553 89.78%
Holding current value
$354,724
Previous $261,000 58.24%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

BUY
$16.59 - $23.77 $186,969 - $267,887
11,270 Added 89.78%
23,823 $413,000
Q2 2023

Jan 12, 2024

SELL
$19.27 - $24.63 $217,153 - $277,555
-11,269 Reduced 47.3%
12,554 $261,000
Q2 2023

Aug 14, 2023

BUY
$19.27 - $24.63 $616 - $788
32 Added 0.26%
12,553 $261,000
Q1 2023

May 15, 2023

SELL
$21.42 - $32.08 $19,085 - $28,583
-891 Reduced 6.64%
12,521 $294,000
Q4 2022

Oct 23, 2023

BUY
$23.31 - $28.61 $62,121 - $76,245
2,665 Added 24.8%
13,412 $374,000
Q4 2022

Feb 13, 2023

BUY
$23.31 - $28.61 $98,298 - $120,648
4,217 Added 45.86%
13,412 $374,000
Q3 2022

Oct 23, 2023

BUY
$23.4 - $34.25 $5,265 - $7,706
225 Added 2.14%
10,747 $251,000
Q3 2022

Nov 14, 2022

SELL
$23.4 - $34.25 $53,609 - $78,466
-2,291 Reduced 19.95%
9,195 $217,000
Q2 2022

Oct 23, 2023

SELL
$31.66 - $38.9 $64,301 - $79,005
-2,031 Reduced 16.18%
10,522 $355,000
Q2 2022

Aug 15, 2022

SELL
$31.66 - $38.9 $192,714 - $236,784
-6,087 Reduced 34.64%
11,486 $384,000
Q1 2022

May 16, 2022

BUY
$30.45 - $39.36 $4,567 - $5,904
150 Added 0.86%
17,573 $614,000
Q4 2021

Feb 14, 2022

BUY
$28.67 - $37.13 $140,655 - $182,159
4,906 Added 39.19%
17,423 $531,000
Q3 2021

Nov 16, 2021

SELL
$28.63 - $35.64 $38,249 - $47,615
-1,336 Reduced 9.64%
12,517 $411,000
Q2 2021

Aug 31, 2021

BUY
$28.45 - $38.0 $394,117 - $526,414
13,853 New
13,853 $419,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.79B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Pathstone Family Office, LLC Portfolio

Follow Pathstone Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Family Office, LLC with notifications on news.